Scientists identify molecule driving one of the deadliest forms of breast cancer
Researchers have identified a molecular switch, miR-342, that drives the spread of aggressive triple-negative breast cancer. The study suggests that existing drugs could be repurposed to treat patients with low levels of this molecule.
Why it matters
This discovery offers a potential pathway for more effective, targeted treatments for one of the most difficult-to-treat forms of breast cancer.
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for Cancer Research, National Cancer Institute, National Institutes of Health Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in